Preparation and application of a fusion protein and vaccine composition thereof
A vaccine composition and fusion protein technology, applied in the field of veterinary biological products, can solve the problems of high morbidity and mortality, difficulty in isolating and cultivating PEDV whole virus, and economic loss
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0073] Preparation, identification and content determination of embodiment 1 fusion protein 1
[0074] According to the COE neutralization table in the S protein fragment of porcine epidemic diarrhea virus (accession number: JN599150.1, AB857233.1, AB857234.1) reported in NCBI (http: / / www.ncbi.nlm.nih.gov) (respectively see SEQ ID No.1, SEQ ID No.3 (artificially synthesized), SEQ ID No.5, SEQ ID No.7), the gene sequence of the neutralizing epitope of SS2-SS6-2C10 combination ( SEQ ID No.9), and the gene sequence of the Fc protein in porcine immunoglobulin IgG (accession number: NM_213828.1) (see SEQ ID No.11) to prepare the fusion protein by means of genetic engineering.
[0075] 1.1 Construction and identification of porcine epidemic diarrhea virus antigenic protein
[0076] When constructing the COE neutralizing epitope in the S protein fragment of porcine epidemic diarrhea virus, specific enzyme cutting sites such as EcoRI and HindIII were introduced at the 5'-end and 3'-e...
Embodiment 2
[0091] The preparation of embodiment 2 porcine epidemic diarrhea virus vaccine composition
[0092] Dilute the fusion protein prepared in Example 1 with pH 7.4 PBS, add aluminum gel adjuvant and mix well, so that the content of the recombinant fusion protein contained in the vaccine composition is as shown in Table 1, while ensuring that the aluminum gel adjuvant The volume ratio with the vaccine composition is 1:5. The prepared vaccine composition was used as an immunogen and stored at 4°C for future use.
[0093] The components contained in the porcine epidemic diarrhea vaccine composition of table 1
[0094]
Embodiment 3
[0095] Example 3 Porcine epidemic diarrhea vaccine composition immune efficacy evaluation
[0096] 3.1 Active immunization test
[0097] Select 64 PEDV antibody and antigen-negative piglets at the age of 3 days, and randomly divide them into 8 groups (see Table 2 for details), 8 pigs / group. Groups 1-1, 1-2, 1-3, 1-4, 1-5, and 1-6 were injected intramuscularly with vaccines prepared in Example 2 respectively at 1-5, 2ml / head; groups 1-7, 1- The 8 groups were blank control group and were immunized with the same dose of PBS solution with pH 7.4. On the 14th day after immunization, the sera of pigs in the immunized group and the control group were collected, and the titers of neutralizing antibodies in the sera of each group were detected. The average antibody titer of each piglet was statistically analyzed using SPSS 15.0 software. At the same time, pigs in the immunization group except groups 1-1, 1-5 and groups 1-7 of the blank control group were orally administered with 1ml...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com